MedPage Today on MSN

CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma

Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high ...
Healio

‘Readily available biomarker’ can predict outcomes in multiple myeloma

Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...
Medscape

Blood Eosinophil Count Shows Promise as a Biomarker for Diagnosis of Eosinophilic Oesophagitis

Blood eosinophil count at a specific threshold shows high sensitivity and specificity for diagnosing eosinophilic ...
EurekAlert!

Analysis of Lymphocyte Subset Differences and Correlations Among the Three Groups. (IMAGE)

(A) Principal component analysis (PCA) of lymphocyte subsets and factors such as age in Control, LC, and LC-PTB groups, and the joint analysis of LC & LC-PTB. PC1 and PC2 represent the first and ...
MedPage Today

NSCLC, Consolidative Immunotherapy, and the Shadow of Lymphopenia

The standard of care for NSCLC is definitive chemoradiation with consolidative immunotherapy; however, treatment-related lymphopenia may result in poorer patient outcomes. Severe lymphopenia at time ...